AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Intro
This chapter dives into the innovative class of sleep medications called dual orexin receptor antagonists, with a focus on doridorexin. It explores how this new approach targeted at wakefulness could reshape treatments for chronic insomnia and discusses the implications of recent research findings.